Pavel E. Medvedev

Pavel E. Medvedev

Auto-generated profile, based on publicly available information

Pavel E. Medvedev

Urology Department, Moscow Clinical Research Center Hospital 52 of Moscow Healthcare Department; Moscow, Russia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2024 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
RTRuslan N. Trushkin
Ruslan N. Trushkin
TITeymur K. Isaev
Teymur K. Isaev
PMPavel E. Medvedev
Pavel E. Medvedev
NSNikolai E. Shcheglov
Nikolai E. Shcheglov
VVValerii V. Variasin
Valerii V. Variasin
LKLaura A. Kesaeva
Laura A. Kesaeva
Introduction: Kidney transplantation is the optimal treatment modality for patients with end-stage chronic kidney disease. The long-term mortality of kidney recipients is 48–82% lower than that of patients on the waiting list. However, the risk of developing malignancies in these patients is twice as high as in the healthy population. Specifically, the incidence of renal cell carcinoma (RCC) in transplant recipients is 10–30 times higher than in non-transplanted patients. The reason for the increased risk is poorly understood, but is most likely related to continuous immunosuppressive therapy. The problem of kidney graft neoplasia has not been adequately addressed in the medical literature. Objective: To determine the incidence of renal cell carcinoma in transplanted kidneys, enhance the efficacy of its treatment, and study the etiology of RCC development. Materials and methods: A retrospective analysis of RCC incidence in kidney grafts was conducted in 3,270 patients who underwent kidney transplantation between 2013 and 2023. We evaluated the effectiveness of surgical interventions for these complications. Patients with histologically confirmed RCC of the transplanted kidney underwent genetic study to determine the etiology of the neoplasm. Results: The incidence of RCC in transplanted kidneys was found to be 0.95% (n = 31), 28 patients underwent laparoscopic resection of the renal transplant tumor, 2 patients were treated with radiofrequency ablation of the tumor. Transplantectomy was performed in 1 patient. Conclusion: Laparoscopic resection is an effective and safe method for the treatment of RCC in kidney transplants. Transplanted kidney cancer originates from the donor tissue. The clear cell variant of transplanted kidney cancer is a genetically determined disease.

29 September 2020 in Experimental and Сlinical Urology
Verified
Journal Article
Closed access
NRN.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian FederationRadiology of the Ministry of Health of Russia
N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – Branch of the National Medical Research Centre of Radiology of the Ministry of Health of Russian FederationRadiology of the Ministry of Health of Russia
NPN.V. Polyakov
N.V. Polyakov
NKN.G. Keshishev
N.G. Keshishev
PMP.E. Medvedev
P.E. Medvedev
SGSh.SH. Gurbanov
Sh.SH. Gurbanov
DMD.S. Merinov
D.S. Merinov

22 November 2024 in Cancer Urology
Verified
Journal Article
Open access
PDF file
RTR. N. Trushkin
R. N. Trushkin
EBE. A. Baryakh
E. A. Baryakh
PMP. E. Medvedev
P. E. Medvedev
YLYu. A. Lagoyskaya
Yu. A. Lagoyskaya
ESE. A. Semenova
E. A. Semenova
TIT. K. Isaev
T. K. Isaev
The article presents a clinical case of mantle cell lymphoma of the prostate in a 75-year-old man who was hospitalized in the Emergency Urological Department of the City Clinical Hospital No. 52 with gross hematuria through cystostomy tube. During examination the patient was found to have prostatomegaly (prostate volume 992 cm3), prostate-specific antigen level was 2.2 ng/mL. Immunohistochemical examination of prostate tissue after adenectomy indicates prostate damage due to mantle cell lymphoma.

25 March 2026 in Experimental and Сlinical Urology
Verified
Journal Article
Closed access
NPN.V. Polyakov
N.V. Polyakov
TRTrushkin
Trushkin
PMP.E. Medvedev
P.E. Medvedev
YLYu.A. Lagoyskaya
Yu.A. Lagoyskaya
AKA.A. Kovalevskiy
A.A. Kovalevskiy
AKAndrei Kaprin
Andrei Kaprin
Introduction. Paragangliomas, also known as chromaffin tumours, are rare neuroendocrine neoplasms arising from paraganglionic tissue located at various sites in the body. These tumours can be either benign or malignant (up to 10% of cases) and their clinical manifestation is often associated with functional activity that may result in the release of catecholamines into the bloodstream. Paragangliomas are most commonly found in the adrenal glands, but can also localise to the bladder region. According to current concepts, this disease develops from embryonic remnants of chromaffin cells located in the sympathetic plexus of the detrusor. Approximately 10% of such tumours are characterised by malignant potential. The present article presents a description of a clinical case of bladder paraganglioma, which demonstrates the stages of diagnosis, determination of treatment tactics and further dynamic follow-up of patients. Materials and Methods. A detailed description of a clinical case of bladder paraganglioma in a 74-year-old female patient on the basis of the State Budgetary Institution "Moscow Clinical Research Center Hospital 52 of Moscow Healthcare Department" was carried out. The study included a comprehensive analysis of clinical and anamnestic data, results of laboratory and instrumental examination and pathohistological examination. Diagnostic methods were: clinical examination, instrumental and morphological methods of research. Clinical case. Patient S. 74 years old came for emergency indications due to difficult urination, blood in the urine. From anamnesis it is known that during the last 6 months she started to notice difficult urination. It was also found out during questioning that there was a crisis course of arterial hypertension. In the course of additional examination a volumetric bladder mass was diagnosed in the area of the right bladder orifice, dilation of the upper urinary tract on the right side. Cystoscopy and transurethral resection of the bladder mass were performed for diatherapeutic purposes. According to the results of morphological examination, the data for bladder paraganglioma were obtained. Conclusion. In a patient with crisis course of arterial hypertension, macrohaematuria, lower urinary tract symptoms it is possible to assume bladder paraganglioma as a differential diagnosis. The inconsistency of diagnostic standards and standards of treatment tactics, the difference of opinion on the efficacy of different methods, which vary from region to region and from medical institution to medical institution, emphasises the need to develop unified protocols for the diagnosis and treatment of bladder paraganglioma.

25 June 2024 in Experimental and Сlinical Urology
Verified
Journal Article
Open access
Tthe Reconstructive Urology Group of the Department of General and Reconstructive Urοlοgy of N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology - branch of the National Medical Research Radiological Center of the Ministry of
the Reconstructive Urology Group of the Department of General and Reconstructive Urοlοgy of N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology - branch of the National Medical Research Radiological Center of the Ministry of
NPN.V. Polyakov
N.V. Polyakov
RMRussia Moscow
Russia Moscow
TRTrushkin
Trushkin
PMP.E. Medvedev
P.E. Medvedev
AKAndrei Kaprin
Andrei Kaprin
Introduction. Currently, stents are used in the treatment of various benign and malignant diseases of the upper urinary tract and urethra. Modern stents made of a superelastic alloy, coated with a polymer, regardless of location, are characterized by higher and longer-lasting patency in terms of decompression and relief of obstruction, fewer irritative symptoms of the genitourinary system and no need for frequent replacement, which leads to improved quality of life in addition to cost savings. Despite promising results, there are few studies in the literature regarding their use, and these tend to be peer-to-peer, retrospective, involving small numbers of patients, and based on the surgeon's personal experience. Materials and methods. In literature review used data about using minimally invasive methods for treatment of ureteral strictures, published in PubMed’s base (https://www.ncbi.nlm.nih.gov/pubmed/), scientific electronic library of RF – Elibrary.ru (https://elibrary.ru/) and also professional endourological association websites. The databases were searched using the following keywords: «ureteral stent», «urethral stent», «allium», «uventa» and «memokath». At the first stage, 93 sources no older than 5 years were found that were relevant to the topic of the review. Conference abstracts, short communications, and duplicate publications were excluded. Then, based on the relevance of the data, the reliability of the sources, the impact factors of the journals and the sequence of presentation of the material in the manuscript, 43 articles in scientific international peer-reviewed journals, practical guidelines and clinical recommendations were selected directly for citation in the review. Results. The stent is one of the most common urological prostheses used in the treatment of obstructive uropathy. The main causes of obstruction of the ureter and urethra include benign and malignant factors. Active introduction of minimally invasive technologies into everyday urological practice using ureteral or urethral stents are effective and safe methods of urine diversion (especially in comorbid patients), however, unfortunately, side effects from the use of these prosthetic systems continue to reduce the quality of life of patients. The use of polymer materials in urology has made it possible to introduce a huge number of non-metallic stents used by urologists, however, due to the occurrence of various kinds of complications, an attempt has been made to introduce a new generation of stents – made of a superelastic alloy, coated with polymer. Stents made of superelastic alloy coated with polymer have been used in the treatment of various pathologies of the ureter and urethra for more than two decades. The need for reliable long-term urinary tract drainage has led to the development of improved urinary tract stent designs such as Memokath, Allium, and Uventa. The main advantages of the latter are a convenient delivery system, a self-expanding mechanism, low adhesive properties, no tissue ingrowth, ease of removal, and no need for frequent replacement. Despite the evolution of ureteral and urethral stent designs, complications continue to arise that limit their use and the search for «ideal» drainage systems continues. Conclusion. Today it is difficult to overestimate the role of drainage systems in the treatment of obstructive urological and oncological diseases. However, despite significant success in their use, prostheses are constantly subject to constant modifications and developments aimed at increasing their suitability, durability, ease of implantation and functionality, while reducing the complications associated with them. Future developments in the field of urogenital prosthetic surgery and urology in general continue to attract interest, and ongoing research into new biomaterials, stem cells and tissue engineering is expanding the boundaries of possible interventions in the human genitourinary tract.

25 September 2025 in Experimental and Сlinical Urology
Verified
Journal Article
Open access
Tthe Reconstructive Urology Group of the Department of General and Reconstructive Urοlοgy of N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center of the Ministry of
the Reconstructive Urology Group of the Department of General and Reconstructive Urοlοgy of N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center of the Ministry of
NPN.V. Polyakov
N.V. Polyakov
RMRussia Moscow
Russia Moscow
TRTrushkin
Trushkin
PMP.E. Medvedev
P.E. Medvedev
AKAndrei Kaprin
Andrei Kaprin
Introduction. Prostatic abscess (PA) is a rare pathological condition occurring in approximately 0.02% of patients with urological diseases. Kidney transplant recipients receiving immunosuppressive therapy are at high risk of developing inflammatory diseases of the urinary tract. PA may occur at any time after kidney transplantation. Diagnosis and treatment of PA in the early post-transplant period require a special approach aimed at both eliminating the infectious process and preserving the function of the transplanted kidney. Clinical case. The presented clinical case describes a 57-year-old patient who was diagnosed with PA one month after kidney transplantation from a deceased donor. The patient presented with fever and dysuria. Urgent pelvic computed tomography and transrectal ultrasound identified two abscesses located in the left and right prostatic lobes. Transperitoneal puncture drainage was performed, and bacteriological analysis of the purulent material confirmed the presence of Klebsiella pneumonia in 107. The drainage catheter was removed after nine days, leading to the resolution of fever, aleviation of dysuric symptoms, improvement in the prostate’s echographic appearance, and a reduction in serum creatinine levels from 309 to 232 μmol/L. To our knowledge, this represents the first documented case of PA in a kidney transplant recipient occurring in the early post-transplant period. Conclusion. In renal transplant recipients receiving immunosuppressive therapy, PA may develop very early after transplantation. The use of the correct approach to the treatment of this complication allows achieving favorable results, preventing complications and preserving the function of the transplanted organ.